ORCHID PHARMA
Quarterly Results Analysis [Jun2026]
ORCHID PHARMA Quarterly Results
| Consolidated | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹304 Cr | ₹238 Cr | ₹207 Cr | ₹194 Cr | ₹263 Cr | ₹237 Cr | ₹217 Cr | ₹223 Cr |
| Expenses | ₹290 Cr | ₹211 Cr | ₹206 Cr | ₹195 Cr | ₹269 Cr | ₹209 Cr | ₹191 Cr | ₹192 Cr |
| Operating Income | ₹14 Cr | ₹27 Cr | ₹2 Cr | ₹-1 Cr | ₹-6 Cr | ₹28 Cr | ₹26 Cr | ₹30 Cr |
| Other Income | ₹2 Cr | ₹7 Cr | ₹6 Cr | ₹11 Cr | ₹12 Cr | ₹4 Cr | ₹8 Cr | ₹8 Cr |
| Interest | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr |
| Depreciation | ₹11 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹11 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr |
| Profit Before Tax | ₹3 Cr | ₹23 Cr | ₹-12 Cr | ₹-3 Cr | ₹-7 Cr | ₹19 Cr | ₹22 Cr | ₹26 Cr |
| Profit After Tax | ₹3 Cr | ₹23 Cr | ₹-12 Cr | ₹-3 Cr | ₹-7 Cr | ₹19 Cr | ₹22 Cr | ₹26 Cr |
| EPS | ₹0.54 | ₹4.69 | ₹-2.49 | ₹-1.13 | ₹-0.95 | ₹4.40 | ₹4.10 | ₹5.37 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ORCHID PHARMA | 1% | -6.6% | 26.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | -1.4% | 21.7% |
| DIVIS LABORATORIES | 2% | 10.3% | 49.5% |
| TORRENT PHARMACEUTICALS | -0.4% | -0.5% | 38.6% |
| CIPLA | -0.5% | -2.5% | -10.2% |
| DR REDDYS LABORATORIES | -1.2% | 0% | -7.1% |
| MANKIND PHARMA | -1.5% | -3.3% | -4.6% |
| LUPIN | -0.6% | -9.4% | 13% |
| ZYDUS LIFESCIENCES | -3.2% | 2.9% | 19.2% |
ORCHID PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 28.01 % |
| Y-o-Y | 15.57 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹304 Cr | 28.01 | |
| Mar2026 | ₹238 Cr | 14.64 | |
| Dec2025 | ₹207 Cr | 7.10 | |
| Sep2025 | ₹194 Cr | -26.47 | |
| Jun2025 | ₹263 Cr | 10.82 | |
| Mar2025 | ₹237 Cr | 9.26 | |
| Dec2024 | ₹217 Cr | -2.41 | |
| Sep2024 | ₹223 Cr | - | |
ORCHID PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -47.88 % |
| Y-o-Y | Positive |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹14 Cr | -47.88 | |
| Mar2026 | ₹27 Cr | 1,618.75 | |
| Dec2025 | ₹2 Cr | Positive | |
| Sep2025 | ₹-1 Cr | Negative | |
| Jun2025 | ₹-6 Cr | Negative | |
| Mar2025 | ₹28 Cr | 6.15 | |
| Dec2024 | ₹26 Cr | -13.10 | |
| Sep2024 | ₹30 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -59.33 % |
| Y-o-Y | Positive |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 4.6% | -59.33 | |
| Mar2026 | 11.31% | 1,408.00 | |
| Dec2025 | 0.75% | Positive | |
| Sep2025 | -0.76% | Negative | |
| Jun2025 | -2.14% | Negative | |
| Mar2025 | 11.78% | -2.89 | |
| Dec2024 | 12.13% | -10.94 | |
| Sep2024 | 13.62% | - | |
ORCHID PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -88.68 % |
| Y-o-Y | Positive |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹3 Cr | -88.68 | |
| Mar2026 | ₹23 Cr | Positive | |
| Dec2025 | ₹-12 Cr | Negative | |
| Sep2025 | ₹-3 Cr | Negative | |
| Jun2025 | ₹-7 Cr | Negative | |
| Mar2025 | ₹19 Cr | -14.77 | |
| Dec2024 | ₹22 Cr | -13.32 | |
| Sep2024 | ₹26 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -91.14 % |
| Y-o-Y | Positive |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 0.85 % | -91.14 | |
| Mar2026 | 9.59 % | Positive | |
| Dec2025 | -5.86 % | Negative | |
| Sep2025 | -1.72 % | Negative | |
| Jun2025 | -2.62 % | Negative | |
| Mar2025 | 8.06 % | -21.97 | |
| Dec2024 | 10.33 % | -11.18 | |
| Sep2024 | 11.63 % | - | |
ORCHID PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -88.49 % |
| Y-o-Y | Positive |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹0.54 | -88.49 | |
| Mar2026 | ₹4.69 | Positive | |
| Dec2025 | ₹-2.49 | Negative | |
| Sep2025 | ₹-1.13 | Negative | |
| Jun2025 | ₹-0.95 | Negative | |
| Mar2025 | ₹4.4 | 7.32 | |
| Dec2024 | ₹4.1 | -23.65 | |
| Sep2024 | ₹5.37 | - | |
You may also like the below Video Courses